Vaccine currently being evaluated in Phase 3 clinical testing. Read More
Study aims to determine safety and efficacy of experimental monoclonal antibodies. Read More
Initial trial to determine if monoclonal antibodies can shorten severity of COVID-19 in outpatients. Read More
Range of new technologies will meet testing needs in diverse settings. Read More
Discovery provides new target for anti-malaria treatments. Read More
ENCODE Project's third phase offers new insights into the organization and regulation of our genes and genome. Read More
NIH-led study of mRNA vaccine supports advance to Phase 3 human trials. Read More
Scientists analyzed 40 years of data from the Framingham Heart Study. Read More
The new five-year program will leverage existing data and technologies to develop solutions for the continent’s most pressing clinical and public health problems. Read More
Multi-site trial to test candidate developed by Moderna and NIH. Read More
